Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Sensing technology set to detect disease in livestock
Livestock diseases cost the UK economy an estimated £1 billion per year in lost productivity.

Sensor systems have the potential to provide more definitive results

New sensing technology set to detect disease and reduce the use of antibiotics in livestock is being developed by veterinary diagnostics firm, Biotangents.

The organisation is using sensing technology to enhance the accuracy of its point-of-care testing platform, to help detect common infections in livestock and reduce the use of antibiotics in farming.

Livestock diseases cost the UK economy an estimated £1 billion per year in lost productivity and mitigation and is a major issue for the global industry. Common infections in livestock, such as bovine viral diarrhoea (BVD), can cause serious immune suppression, bovine pneumonia and calf mortality, and often expensive treatment with secondary antibiotics.

Biotangents is developing an electrochemical sensing system to upgrade its prototype on-farm testing equipment in collaboration with the University of Strathclyde and CENSIS, an innovation centre for sensor and imaging systems.
They say specialist sensor systems have the potential to provide more definitive results, helping to increase the accuracy of diagnosis.

Biotangents are aiming for future iterations to be able to test for various infections and diseases at the same time, from BVD to mastitis. Recently, the business secured £1.5 billion of new investment for the development of its technology, following a second round of fundraising.

“The management and treatment of infection is essential to helping cattle stay healthy, improving welfare, and ultimately making the industry more sustainable,” said Andy Hall-Ponselè, Biotangents’ operations director.

“An accurate, speedy diagnosis is the first step in helping to limit the spread of diseases, such as BVD, which can be passed on by cows touching noses or sharing troughs.”

He continued: “Five new infectious diseases are emerging each year, and many of these can be passed on to humans. By using our advanced Moduleic Sensing diagnostic platform, we aim to enable vets to identify and manage infectious diseases at the earliest possible opportunity and minimise their chances of spreading.”

Until now, diagnostic test results could take up to a week to be returned from a central lab. The new point-of-care test, however, can produce BVD test results on the same day and potentially within one hour.

By allowing vets to extract DNA on-site, and detect infection quickly, any affected animals can be isolated for remedial action, preventing disease spread.
The test also aims to make the use of antibiotics more targeted, reducing the risk of livestock resistant to treatments.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.